Drugs / Thioctic Acid
Thioctic Acid
Trials 6
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01808300 | Feb → Jul 2013 | — | Unimed Pharmaceuticals | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00002154 | — | HIV infectious disease, cognitive disorder | The Dana Foundation | Completed | No outcome recorded |
| Phase 32 trials · 1 met primary · 1 missed | ||||||
| Phase 3 | NCT00328601 | Feb → Jun 2005 | diabetic polyneuropathy | MEDA Pharma GmbH & Co. KG | Completed | Met primary |
| Phase 3 | NCT00977483 | May 1998 → Jan 2005 | diabetic polyneuropathy | MEDA Pharma GmbH & Co. KG | Completed | Missed primary |
| Phase 41 trial | ||||||
| Phase 4 | NCT03914404 | Jan → Mar 2016 | diabetic polyneuropathy | Chonbuk National University Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00004770 | Oct 1995 → ? | pure mitochondrial myopathy | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06253429 Comparator | Jan 2023 → Jan 2024 | type 1 diabetes mellitus | Ain Shams University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Thioctic acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01808300 ↗ |
| Known as | alpha-lipoic acid | “600mg tablet Thioctic Acid (alpha-lipoic acid) once daily throughout the trial” NCT00977483 ↗ |
| Known as | LipoA HR Tab. 600mg | “Thioctic Acid(LipoA HR Tab. 600mg) once a day and 1 tablet at a time.” NCT03914404 ↗ |
| Route | Oral | “orally (tablet) administered thioctic acid” NCT00328601 ↗ |